Product NDC: | 52584-215 |
Proprietary Name: | Naloxone Hydrochloride |
Non Proprietary Name: | Naloxone Hydrochloride |
Active Ingredient(s): | .4 mg/mL & nbsp; Naloxone Hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52584-215 |
Labeler Name: | General Injectables & Vaccines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA070256 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100801 |
Package NDC: | 52584-215-01 |
Package Description: | 1 VIAL, SINGLE-DOSE in 1 BAG (52584-215-01) > 1 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 52584-215-01 |
Proprietary Name | Naloxone Hydrochloride |
Package Description | 1 VIAL, SINGLE-DOSE in 1 BAG (52584-215-01) > 1 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 52584-215 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Naloxone Hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20100801 |
Marketing Category Name | ANDA |
Labeler Name | General Injectables & Vaccines, Inc |
Substance Name | NALOXONE HYDROCHLORIDE |
Strength Number | .4 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |